The Relation Between Symptom Improvement and Gastric Emptying in the Treatment of Diabetic and Idiopathic Gastroparesis
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: The relationship between symptom improvement (SI) and acceleration of gastric emptying (GE) for different drugs used in the treatment of idiopathic and diabetic gastroparesis is uncertain. In this paper we examined the study-specific correlations between SI and GE, and we performed a meta-regression analysis of the association across multiple studies. METHODS: The MEDLINE database (1,946 to present) was searched, and only controlled trials or trials with an established effective comparator that compared both SI and GE were included. RESULTS: Studies were identified for metoclopramide (n=6), domperidone (n=6), cisapride (n=14), erythromycin (n=3), botulinum toxin (n=2), and levosulpiride (n=3). Even though most drugs concomitantly improved symptoms and accelerated GE, no study reported a significant correlation between SI and GE. Moreover, a correlation analysis over all studies using meta-regression did not show a significant relationship between SI and GE. Our findings need to be qualified by inconsistencies in study methods, which is a limitation but also suggests that our findings are robust to methodological factors. CONCLUSIONS: In this review, no evidence of a relationship between SI and GE was identified for different drugs used for the treatment of gastroparesis. This finding questions the use of GE measurement to direct drug development for gastroparesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Janssen, P., Oudenhove, L. V., Bisschops, R., & Tack, J. F. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.078 · Cited by 19
Self-citationRetractedMeta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Improvement of Gastric Emptying in Diabetic Gastroparesis by Erythromycin: Preliminary Studies
Janssens, J., Peeters, T. L., Vantrappen, G., Tack, J., Urbain, J. L., De Roo, M., Muls, E., & Bouillon, R. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004123221502 · Cited by 753
Self-citationPathophysiology and treatment of functional dyspepsia
Tack, J., Bisschops, R., & Sarnelli, G. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.05.030 · Cited by 518
Self-citationRevicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., & Tack, J. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000021689.86296.e4 · Cited by 418
Self-citationRevicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., & Tack, J. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01612.x · Cited by 383
Self-citationBotulinum Toxin A for the Treatment of Delayed Gastric Emptying
Friedenberg, F. K., Palit, A., Parkman, H. P., Hanlon, A., & Nelson, D. B. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01676.x · Cited by 370
ASYMPTOMATIC GASTRIC RETENTION IN DIABETICS (GASTROPARESIS DIABETICORUM)
KASSANDER, P. (1958) · Annals of Internal Medicine · doi:10.7326/0003-4819-48-4-797 · Cited by 370
ARTS, J., HOLVOET, L., CAENEPEEL, P., BISSCHOPS, R., SIFRIM, D., VERBEKE, K., JANSSENS, J., & TACK, J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03467.x · Cited by 368
Self-citationParkman, H. P., Yates, K., Hasler, W. L., Nguyen, L., Pasricha, P. J., Snape, W. J., Farrugia, G., Koch, K. L., Abell, T. L., McCallum, R. W., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.015 · Cited by 349
Cited by
Ford, A. C., Mahadeva, S., Carbone, M. F., Lacy, B. E., & Talley, N. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30469-4 · Cited by 517
The stomach in health and disease
Hunt, R. H., Camilleri, M., Crowe, S. E., El-Omar, E. M., Fox, J. G., Kuipers, E. J., Malfertheiner, P., McColl, K. E. L., Pritchard, D. M., Rugge, M., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307595 · Cited by 403
Self-citationGastric emptying and glycaemia in health and diabetes mellitus
Phillips, L. K., Deane, A. M., Jones, K. L., Rayner, C. K., & Horowitz, M. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.202 · Cited by 273
Pasricha, P. J., Grover, M., Yates, K. P., Abell, T. L., Bernard, C. E., Koch, K. L., McCallum, R. W., Sarosiek, I., Kuo, B., Bulat, R., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.01.230 · Cited by 268
Advances in the diagnosis and classification of gastric and intestinal motility disorders
on behalf of the International Working Group for Disorders of Gastrointestinal Motility and Function, Keller, J., Bassotti, G., Clarke, J., Dinning, P., Fox, M., Grover, M., Hellström, P. M., Ke, M., Layer, P., et al. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.7 · Cited by 265
Self-citationBharucha, A. E., Kudva, Y. C., & Prichard, D. O. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00161 · Cited by 252
Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study
Carbone, F., Van den Houte, K., Clevers, E., Andrews, C. N., Papathanasopoulos, A., Holvoet, L., Van Oudenhove, L., Caenepeel, P., Arts, J., Vanuytsel, T., et al. (2019) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000304 · Cited by 206
Self-citationCamilleri, M., & Sanders, K. M. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.10.028 · Cited by 151
Fundamentals of Neurogastroenterology: Physiology/Motility – Sensation
Boeckxstaens, G., Camilleri, M., Sifrim, D., Houghton, L. A., Elsenbruch, S., Lindberg, G., Azpiroz, F., & Parkman, H. P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.030 · Cited by 142
Koch, K. L., & Calles-Escandón, J. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2014.11.005 · Cited by 92
“associated with gastroparesis.(57,58) Domperidone is a dopamine 2 receptor agonist that does not cross the blood-brain barrier, improves nausea and gastric dysrhythmias, and may improve the rate of gastric emptying in somepatientswith diabetic gastroparesis.”
BackgroundDiabetic Enteropathy: From Molecule to Mechanism-Based Treatment
Meldgaard, T., Olesen, S. S., Farmer, A. D., Krogh, K., Wendel, A. A., Brock, B., Drewes, A. M., & Brock, C. (2018) · Journal of Diabetes Research · doi:10.1155/2018/3827301 · Cited by 83
“However, it must be underlined that there is no absolute association between symptom improvement and changes in gastric motility after treatment with prokinetics [81] and most prokinetic drugs are limited to short-term use due to the risk of irreversible tardive dyskinesia (D2-receptor antagonists) and currently subje…”
BackgroundCalles-Escandón, J., Koch, K. L., Hasler, W. L., Van Natta, M. L., Pasricha, P. J., Tonascia, J., Parkman, H. P., Hamilton, F., Herman, W. H., Basina, M., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194759 · Cited by 55
Carbone, F., De Buysscher, R., Van den Houte, K., Schol, J., Goelen, N., & Tack, J. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.03.023 · Cited by 55
Self-citationMacrophages in diabetic gastroparesis – the missing link?
Neshatian, L., Gibbons, S. J., & Farrugia, G. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12418 · Cited by 55
Schol, J., Huang, I.-H., Carbone, F., Fernandez, L. M. B., Gourcerol, G., Ho, V., Kohn, G., Lacy, B. E., Colombo, A. L., Miwa, H., et al. (2025) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00284-x · Cited by 32
Self-citationDietary Interventions for Gastroparesis: A Systematic Review
Eseonu, D., Su, T., Lee, K., Chumpitazi, B. P., Shulman, R. J., & Hernaez, R. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac037 · Cited by 22
Time trends in gastroparesis treatment
Dudekula, A., Rahim, S., & Bielefeldt, K. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3369-y · Cited by 21
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions
Caturano, A., Cavallo, M., Nilo, D., Vaudo, G., Russo, V., Galiero, R., Rinaldi, L., Marfella, R., Monda, M., Luca, G., et al. (2024) · Gastrointestinal Disorders · doi:10.3390/gidisord6010016 · Cited by 17
“Moreover, therapeutic trials utilizing prokinetic agents for gastroparesis have revealed a lack of consistent correlation between improvements in gastric emptying and symptom relief [85].”
BackgroundNutritional Management in Functional Dyspepsia and Gastroparesis
Störsrud, S., Algera, J. P., & Törnblom, H. (2025) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2025.102079 · Cited by 3
Self-citation
Metadata
- Authors
- Janssen, P., Harris, S. M., Jones, M., Masaoka, T., Farré, R., Törnblom, H., Van Oudenhove, L., Simrén, M., & Tack, J.
- Venue
- American Journal of Gastroenterology
- Published
- 2013-09
- Volume
- 108
- Issue
- 9
- Pages
- 1382-1391
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W1980456997
- Cited by
- 260
- References
- 58
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.